Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression.
about
Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment.Heart failure in patients with chronic kidney disease: a systematic integrative reviewEpidemiology, diagnosis and management of hypertension among patients on chronic dialysis.Impact of rapid ultrafiltration rate on changes in the echocardiographic left atrial volume index in patients undergoing haemodialysis: a longitudinal observational studyLong-term effects of spironolactone in peritoneal dialysis patientsThe effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal TrialPatterns of late gadolinium enhancement in chronic hemodialysis patientsPredicting mortality in haemodialysis patients: a comparison between lung ultrasonography, bioimpedance data and echocardiography parameters.Intradialytic hypotension and cardiac remodeling: a vicious cycle.The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences.Longitudinal changes of cardiac structure and function in CKD (CASCADE study).Shorter dialysis times are associated with higher mortality among incident hemodialysis patients.Electrocardiographic left ventricular hypertrophy and outcome in hemodialysis patients.Circulating MiR-133a as a biomarker predicts cardiac hypertrophy in chronic hemodialysis patients[Echocardiographic abnormalities in chronic hemodialysis patients: prevalence and risk factors].Markers of increased cardiovascular risk in patients with chronic kidney disease.In-center hemodialysis six times per week versus three times per week.Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass.Consequences of frequent hemodialysis: comparison to conventional hemodialysis and transplantation.Left ventricular mass in dialysis patients, determinants and relation with outcome. Results from the COnvective TRansport STudy (CONTRAST).The relationship of initial transferrin saturation to cardiovascular parameters and outcomes in patients initiating dialysisDiastolic dysfunction is an independent predictor of cardiovascular events in incident dialysis patients with preserved systolic functionCardiac remodelling and functional alterations in mild-to-moderate renal dysfunction: comparison with healthy subjectsAssociation between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study.Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD.Relative Importance of Aortic Stiffness and Volume as Predictors of Treatment-Induced Improvement in Left Ventricular Mass Index in Dialysis.Inflammation, Endothelial Dysfunction and Increased Left Ventricular Mass in Chronic Kidney Disease (CKD) Patients: A Longitudinal StudyDeterminants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.Randomized Controlled Trial of Individualized Dialysate Cooling for Cardiac Protection in Hemodialysis PatientsExperimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection.Changes in echocardiographic parameters according to the rate of residual renal function decline in incident peritoneal dialysis patients.Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis.NT-proBNP: is it a more significant risk factor for mortality than troponin T in incident hemodialysis patients?Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease.Early cardiac dysfunction in pediatric patients on maintenance dialysis and post kidney transplant.Cardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients.Which Biomarker is the Best for Predicting Mortality in Incident Peritoneal Dialysis Patients: NT-ProBNP, Cardiac TnT, or hsCRP?: A Prospective Observational StudyCharacterisation of cardiomyopathy by cardiac and aortic magnetic resonance in patients new to hemodialysisEffects of frequent hemodialysis on ventricular volumes and left ventricular remodeling.A randomized trial of hemodiafiltration and change in cardiovascular parameters
P2860
Q26773120-1DE0B640-CB1D-4DB1-B2FC-FC9C5EBC658EQ26824149-CCABFA80-F578-4864-93BE-48EF39444FE5Q30248239-7A6219DD-A5E2-4A2B-BF91-BEA29A71A18DQ30362588-7EF0D6D1-B020-4E27-857C-6A2BE144AAEEQ30413119-13261636-1EA5-4C46-A633-6090D13AF4DCQ30422442-63E94DB3-17B6-4907-BC1C-9F7FA5FCE10DQ30434860-951B7A5F-4FA8-427E-BD6B-55CAF096934AQ30653519-09B6F241-A0B9-4840-A8EB-1C0EF6A253A8Q33359991-4C02E4BC-7E8F-4548-8CDF-13322AE9B8BCQ33571213-376DD3A8-1A3D-407F-A787-66EF01FE7369Q33814919-22ED7BD8-243E-4589-BF96-1929A1551B4BQ33829876-84683189-23A9-4ED6-9606-2FDFF6BED25EQ34243856-F467ECF0-E165-41FC-89BF-F7F99966349CQ34337303-7F208184-0ABF-43DE-8778-86C78558C2D1Q34543253-BAF137F6-413A-4F41-973B-F2784F9B1B57Q34582124-FE68F9EE-009B-48EA-9941-4255A29C85E3Q34588347-4C06BBD9-D77A-4E03-BB86-89603A5F4805Q34820403-76483BFE-690B-4C60-9E07-860134945F62Q35048989-314E3087-A05F-4536-AE61-A0FEAF178C94Q35088034-A76AA375-B843-4DC7-A1A6-3C6A99C007A5Q35088131-D4C66EB8-F0EB-470F-9E54-1F227EB3048CQ35147914-84548608-1F64-4EB8-8C38-1AB5CCE7613EQ35509396-7C5B2178-B976-427A-8EE6-63F91A71D2DCQ35536642-3CA12B11-8505-48B0-AF48-08511863B18AQ35588217-5B7980C0-0459-4D64-A4EE-5B14EF2F4B4DQ35769247-6BE7EA59-E5AB-45E0-B8EC-4ACC28ED5F79Q35784920-F3F8200D-3799-4D6C-B1BA-5181AD770DE5Q35895880-DE87BD1D-044D-4CC1-AAC9-9B3C91060F62Q35922682-C58C6E2F-0B00-4243-AF20-6B1B57089EABQ35950332-58059345-8E95-46DA-B756-30F076F15277Q36009530-7CDEE029-BC4B-4229-AE8F-84ACFA182799Q36090656-2012CA2A-BD16-4147-A2A6-4944BCAEB982Q36152500-CCC8C5AD-9AAC-4893-907D-A55316B96685Q36420791-8E379000-67E3-404B-B0B0-39A5DF2CBD15Q36935567-5A785371-E1D8-4D3B-9542-686A9B705DEFQ36945030-12B57887-8A2D-45A6-A5FB-F29DDA7D199DQ37026079-8E8DDDEF-633B-4FC5-A1DF-724533248579Q37053525-A9ACC904-0F52-4A05-815E-D964F47E2AE1Q37359044-7CA30ED3-F922-4B3E-9014-291F6807F29EQ37621559-78BEAA2D-1919-4B8B-9759-B9855CEE9F38
P2860
Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Left ventricular mass monitori ...... cular hypertrophy progression.
@en
Left ventricular mass monitori ...... cular hypertrophy progression.
@nl
type
label
Left ventricular mass monitori ...... cular hypertrophy progression.
@en
Left ventricular mass monitori ...... cular hypertrophy progression.
@nl
prefLabel
Left ventricular mass monitori ...... cular hypertrophy progression.
@en
Left ventricular mass monitori ...... cular hypertrophy progression.
@nl
P2093
P50
P1433
P1476
Left ventricular mass monitori ...... icular hypertrophy progression
@en
P2093
Alessandro Cataliotti
Francesca Mallamaci
Francesco A Benedetto
Giovanni Tripepi
Giuseppe Giacone
P304
P356
10.1111/J.1523-1755.2004.00530.X
P407
P577
2004-04-01T00:00:00Z
P5875
P6179
1009629187